ASTRAZENECA PHARMA INDIA
|
|
BOM : 506820     NSE : ASTRAZEN     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jun 24,2022 |
Price(EOD): ₹ 2,731.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 6,828.88 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
ASTRAZENECA PHARMA INDIA | 2% | 3.1% | -25.4% |
SUN PHARMACEUTICAL INDUSTRIES | 2.4% | -8.5% | 23.8% |
DIVIS LABORATORIES | 4.3% | 6.7% | -12.6% |
DR REDDYS LABORATORIES | 3.8% | 0% | -18.7% |
CIPLA | 0.8% | -3.2% | -2.4% |
GLAND PHARMA | 2.4% | -7.3% | -17.9% |
PIRAMAL ENTERPRISES | 3.9% | -11% | -33.4% |
CADILA HEALTHCARE | 5.7% | -5.1% | -45.1% |
TORRENT PHARMACEUTICALS | 4.1% | -0.9% | -2.5% |
FUNDAMENTAL ANALYSIS OF ASTRAZENECA PHARMA INDIA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF ASTRAZENECA PHARMA INDIA
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
73.19
P/E Calculated based on EPS of 37.32
[ Mar2021 - Standalone Results ] 15.02
P/B Calculated based on Book Value of 181.83
[ Mar2021 - Standalone Results ] 8.48
P/S Calculated based on Revenues of 805.6 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
19% 55% 56% |
SHARE PRICE MOMENTUM OF ASTRAZENECA PHARMA INDIA
ASTRAZENECA PHARMA INDIA vs SENSEX
DEBT OF ASTRAZENECA PHARMA INDIA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF ASTRAZENECA PHARMA INDIA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF ASTRAZENECA PHARMA INDIA
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
15.68% 158.82% 127.67% 145.04% |
10.32% -6.06% 0.52% 2.59% |
QtrlyTrend |
6 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
ASTRAZENECA PHARMA INDIA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 3.1% | -1.8% | -13% |
S&P BSE 500 | 2.5% | -2% | -1% |
S&P BSE ALLCAP | 2.5% | -2% | -0.8% |
S&P BSE 400 MIDSMALLCAP | 2% | -1.6% | -1.9% |
S&P BSE MIDSMALLCAP | 2% | -1.4% | -2% |
S&P BSE 250 SMALLCAP | 1.8% | -2.5% | -3.9% |
S&P BSE SMALL CAP | 1.6% | -2.4% | -1.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | 2.5% | -2% | -1% |
NIFTY500 MULTICAP 50:25:25 | 2.3% | -2% | -1.3% |
NIFTY MID SMALL400 | 2% | -1.7% | -1.6% |
NIFTY SMALLCAP250 | 1.7% | -2.4% | -3.2% |
You may also like the below Video Courses
FAQ about ASTRAZENECA PHARMA INDIA
Is ASTRAZENECA PHARMA INDIA good for long term investment?
As on Jun 24,2022, the Fundamentals of ASTRAZENECA PHARMA INDIA look Strong and hence it may be good for long term investment! See Financial Performance of ASTRAZENECA PHARMA INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is ASTRAZENECA PHARMA INDIA UnderValued or OverValued?
As on Jun 24,2022, ASTRAZENECA PHARMA INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of ASTRAZENECA PHARMA INDIA ?
As on Jun 24,2022, the Intrinsic Value of ASTRAZENECA PHARMA INDIA is Rs. 1,762.02 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 2,292.38
Fair Value [Median EV / Sales Model] : Rs. 1,762.02
Fair Value [Median Price / Sales Model] : Rs. 1,746.90
Median Fair Value of ASTRAZENECA PHARMA INDIA : Rs. 1,762.02
Is ASTRAZENECA PHARMA INDIA trading at a Premium or Discount?
As on Jun 24,2022, ASTRAZENECA PHARMA INDIA is trading at a Premium of 55% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
